Recognition of E‐cadherin on epithelial cells by the mucosal T cell integrin α<sub>M290</sub>β7 (αEβ7)

European Journal of Immunology - Tập 25 Số 3 - Trang 852-856 - 1995
Paula Karecla1, Simon J. Bowden, Shawn J. Green, P J Kilshaw
1Department of Immunology, Babraham Institute, Cambridge.

Tóm tắt

AbstractThe integrin αM290β7 on the surface of a T cell hybridoma, MTC‐1, mediated adhesion of these cells to the mouse epithelial cell line CMT93. This interaction was critically dependent on the presence of divalent cations; Mn2+ strongly promoted adhesion, Ca2+ was ineffective and Mg2+ gave intermediate results. Antibodies to molecules on the surface of CMT93 cells were tested for inhibition of adhesion. One monoclonal antibody (mAb) against E‐cadherin, ECCD‐2, was found to have significant inhibitory activity. Other mAb to E‐cadherin and antibodies to other molecules had no effect. To show that inhibition by ECCD‐2 was specific for adhesion mediated by αM290β7, MTC‐1 cells were induced to adhere to CMT93 via the LFA‐1/ICAM‐1 pathway. For this purpose, the epithelial cells were treated with interferon‐γ and tumor necrosis factor‐α to induce ICAM‐1 expression and, in addition, αM290β7 on MTC‐1 cells was down‐regulated by culturing the cells in the absence of transforming growth factor β. Under these circumstances adhesion of MTC‐1 cells to CMT93 was inhibited by an antibody to LFA‐1 but not by ECCD‐2. Transfection of mouse L cells with cDNA for mouse E‐cadherin enabled MTC‐1 cells to adhere to them through the αM290β7 integrin; this interaction was inhibited both by ECCD‐2 and by blocking antibody against the integrin. These data strongly suggest that E‐cadherin is a principal ligand for αM290β7.

Từ khóa


Tài liệu tham khảo

10.1016/S0021-9258(17)37563-4

10.1016/1074-7613(94)90070-1

10.1016/0165-2478(88)90056-9

10.1002/eji.1830201008

10.1002/eji.1830170910

10.1002/eji.1830211041

10.1073/pnas.89.5.1924

10.1002/eji.1830231246

10.1002/eji.1830240322

10.1002/eji.1830230735

Cepek K. L., 1993, J. Immunol., 150, 3459, 10.4049/jimmunol.150.8.3459

Roberts A. I., 1993, Cancer Res., 53, 1608

10.1083/jcb.122.5.1103

10.1247/csf.11.245

10.1038/372190a0

10.1002/j.1460-2075.1987.tb02697.x

10.1016/S0021-9258(19)47297-9

10.1042/bj2410591

Vleminckx K. L., 1994, Cancer Res., 54, 873

10.1016/0968-0004(92)90315-Z

10.1002/bies.950141104

10.1016/0092-8674(90)90222-Z

10.1016/0925-4773(90)90134-8

10.1146/annurev.bi.59.070190.001321

10.1146/annurev.cb.08.110192.001515

10.1083/jcb.125.6.1341

10.1016/0092-8674(90)90368-O

10.1073/pnas.87.11.4246

10.1083/jcb.125.6.1353

10.1002/eji.1830221120